This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignees: Assistance Publique-Hopitaux De Paris, Centre National De La Recherche Scientifique, Institut Pasteur. Active years: 2014.
Company Filing History:
1 out of 331 
1 out of 5,383 
1 out of 897 
Years Active: 2014
Title: Elisabeth Couve: Innovator in Molecular Detection
Introduction
Elisabeth Couve is a notable inventor based in Rambouillet, France. She has made significant contributions to the field of molecular biology, particularly in the detection of highly-virulent bacterial clones. Her work has implications for public health and disease management.
Latest Patents
Elisabeth Couve holds 1 patent related to polynucleotides that enable the rapid, simple, and specific detection of Group B highly-virulent ST-17 clones. This invention also encompasses the polypeptides encoded by the polynucleotides, as well as antibodies directed against these polypeptides. Additionally, her patent includes kits and methods for the specific detection of these clones, utilizing the polynucleotides, polypeptides, or antibodies.
Career Highlights
Throughout her career, Elisabeth has worked with prestigious institutions such as Institut Pasteur and the Centre National de la Recherche Scientifique. These organizations are renowned for their contributions to scientific research and public health.
Collaborations
Elisabeth has collaborated with esteemed colleagues, including Claire Poyart and Marie-Cécile Lamy. Their joint efforts have further advanced the research in molecular detection and diagnostics.
Conclusion
Elisabeth Couve's innovative work in the field of molecular biology highlights her commitment to improving detection methods for bacterial infections. Her contributions are vital for enhancing public health measures and advancing scientific knowledge.